Letter in response to the LEADR ICD lead study: Is thinner better?
- PMID: 36542761
- DOI: 10.1111/jce.15786
Letter in response to the LEADR ICD lead study: Is thinner better?
Comment on
-
The LEADR ICD lead study: Is thinner better?J Cardiovasc Electrophysiol. 2023 Feb;34(2):268-269. doi: 10.1111/jce.15750. Epub 2022 Nov 15. J Cardiovasc Electrophysiol. 2023. PMID: 36378785 No abstract available.
-
Cable-based ICD lead study.J Cardiovasc Electrophysiol. 2023 Feb;34(2):489. doi: 10.1111/jce.15787. Epub 2023 Jan 14. J Cardiovasc Electrophysiol. 2023. PMID: 36542766 No abstract available.
References
REFERENCES
-
- Anderson C, Olshansky B. The LEADR ICD study: is thinner better? J Cardiovasc Electrophysiol. 2022.
-
- Crossley GH. To the Editor. J Cardiovasc Electrophysiol. 2022.
-
- Crossley GH, Sanders P, De Fillipo P, et al. Rationale and design of the lead evaluAtion for defibrillation and reliability (LEADR) study: safety and efficacy of a novel ICD lead design. J Cardiovasc Electrophysiol. 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
